Prospects for the development of animal models for the study of bipolar disorder

Bipolar Disorders: Basic Mechanisms and Therapeutic Implications, Second Edition

Volumn , Issue , 2007, Pages 19-31

  Einat, Haim ^a   Shaldubina, Alona ^b   Bersudsky, Yuly ^b   Belmaker, R H ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84953254459     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (76)

1. Kofman O, Belmaker RH. Animal models of mania and bipolar affective disorders, In: Soubrie P, ed. Anxiety, Depression and Mania. New York: Karger, 1991:103-121.
2. Einat H, Manji HK, Belmaker RH. New approaches to modeling bipolar disorder. Psychopharmacol Bull 2003; 37(1):47-63.
3. Shaldubina A, Einat H, Szechtman H, et al. Preliminary evaluation of oral anticonvulsant treatment in the quinpirole model of bipolar disorder. J Neural Transm 2002; 109(3):433-440.
4. Lerer B, Ebstein RP, Felix A, et al. Lithium amelioration of reserpine-induced hypoactivity in rats. Int Pharmacopsychiatry 1980; 15(6):338-343.
5. Einat H, Karbovski H, Korik J, et al. Inositol reduces depressive-like behaviors in two different animal models of depression. Psychopharmacology (Berl) 1999; 144(2): 158-162.
6. Belmaker RH, Lerer B, Klein E, et al. The use of behavioral methods in the search for compounds with lithium-like activity. In: Levy A, Spiegelstein MY, eds. Behavioral Models and the Analysis of Drug Action. Amsterdam: Elsevier, 1982:343-356.
7. Borison RL, Sabelli HC, Maple PJ, et al. Lithium prevention of amphetamine-induced “manic” excitement and of reserpine-induced “depression” in mice: possible role of 2-phenylethylamine. Psychopharmacology (Berl) 1978; 59(3):259-262.
8. Ebstein RP, Eliashar S, Belmaker RH, et al. Chronic lithium treatment and dopaminemediated behavior. Biol Psychiatry 1980; 15(3):459-467.
9. Anand A, Verhoeff P, Seneca N, et al. Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry 2000; 157(7):1108-1114.
10. Murphy DL, Brodie HK, Goodwin FK, et al. Regular induction of hypomania by L-dopa in “bipolar” manic-depressive patients. Nature 1971; 229(5280):135-136.
11. Huey LY, Janowsky DS, Judd LL, et al. Effects of lithium carbonate on methylphenidateinduced mood, behavior, and cognitive processes. Psychopharmacology (Berl) 1981; 73(2):161-164.
12. Van Kammen DP, Murphy DL. Attenuation of the euphoriant and activating effects of d- and l-amphetamine by lithium carbonate treatment. Psychopharmacologia 1975; 44(3):215-224.
13. Tecce JJ, Cole JO. Amphetamine effects in man: paradoxical drowsiness and lowered electrical brain activity (CNV). Science 1974; 185(149):451-453.
14. Angrist B, Gershon S. Variable attenuation of amphetamine effects by lithium. Am J Psychiatry 1979; 136(6):806-810.
15. Gould TJ, Keith RA, Bhat RV. Differential sensitivity to lithium’s reversal of amphetamine-induced open-field activity in two inbred strains of mice. Behav Brain Res 2001; 118(1):95-105.
16. Beaulieu JM, Sotnikova TD, Yao WD, et al. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 2004; 101(14):5099-5104. Epub 2004 Mar 24.
17. Nixon MK, Hascoet M, Bourin M, et al. Additive effects of lithium and antidepressants in the forced swimming test: further evidence for involvement of the serotoninergic system. Psychopharmacology (Berl) 1994; 115(1-2):59-64.
18. Berggren U. Effects of chronic lithium treatment on brain monoamine metabolism and amphetamine-induced locomotor stimulation in rats. J Neural Transm 1985; 64(3-4): 239-250.
19. Berggren U, Tallstedt L, Ahlenius S, et al. The effect of lithium on amphetamine-induced locomotor stimulation. Psychopharmacology (Berl) 1978; 59(1):41-45.
20. Berggren U, Engel J, Liljequist S. The effect of lithium on the locomotor stimulation induced by dependence-producing drugs. J Neural Transm 1981; 50(2-4):157-164.
21. Flemenbaum A. Does lithium block the effects of amphetamine? A report of three cases. Am J Psychiatry 1974; 131(7):820-821.
22. Hamburger-Bar R, Robert M, Newman M, et al. Interstrain correlation between behavioural effects of lithium and effects on cortical cyclic AMP. Pharmacol Biochem Behav 1986; 24(1):9-13.
23. Lerer B, Globus M, Brik E, et al. Effect of treatment and withdrawal from chronic lithium in rats on stimulant-induced responses. Neuropsychobiology 1984; 11(1):28-32.
24. Arriaga F, Dugovic C, Wauquier A. Effects of lithium on dopamine behavioural supersensitivity induced by rapid eye movement sleep deprivation. Neuropsychobiology 1988; 20(1):23-27.
25. Cappeliez P, Moore E. Effects of lithium on an amphetamine animal model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 1990; 14(3):347-358.
26. Fessler RG, Sturgeon RD, London SF, et al. Effects of lithium on behaviour induced by phencyclidine and amphetamine in rats. Psychopharmacology (Berl) 1982; 78(4): 373-376.
27. Pittman KJ, Jakubovic A, Fibiger HC. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat. Psychopharmacology (Berl) 1984; 82(4):371-377.
28. Gould TD, O’Donnell KC, Picchini AM, Manji HK. Strain differences in lithium attenuation of D-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium. Neuropschopharmacology 2006.
29. Einat H, Einat D, Allan M, et al. Associational and nonassociational mechanisms in locomotor sensitization to the dopamine agonist quinpirole. Psychopharmacology (Berl) 1996; 127(2):95-101.
30. Decker S, Grider G, Cobb M, et al. Open field is more sensitive than automated activity monitor in documenting ouabain-induced hyperlocomotion in the development of an animal model for bipolar illness. Prog Neuropsychopharmacol Biol Psychiatry 2000; 24(3):455-462.
31. Einat H, Szechtman H. Environmental modulation of both locomotor response and locomotor sensitization to the dopamine agonist quinpirole. Behav Pharmacol 1993; 4(4):399-403.
32. Silverstone PH, Pukhovsky A, Rotzinger S. Lithium does not attenuate the effects of D-amphetamine in healthy volunteers. Psychiatry Res 1998; 79(3):219-226.
33. Wald D, Ebstein RP, Belmaker RH. Haloperidol and lithium blocking of the mood response to intravenous methylphenidate. Psychopharmacology (Berl) 1978; 57(1):83-87.
34. Ebstein R, Belmaker R, Grunhaus L, et al. Lithium inhibition of adrenaline-stimulated adenylate cyclase in humans. Nature 1976; 259(5542):411-413.
35. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003; 160(4):636-645.
36. Gould TD, Gottesman II. Psychiatric endophenotypes and the development of valid animal models. Genes Brain and Behavior 2006; 5(2):113-119.
37. Hasler G, Drevets WC, Gould TD, Gottesman II, Manji HK. Toward constructing an endophenotype strategy for bipolar disorder. Biological Psychiatry 2006; 60(2):93-105.
38. O’Brien WT, Harper AD, Jove F, et al. Glycogen synthase kinase-3beta haploinsufficiency mimics the behavioral and molecular effects of lithium. J Neurosci 2004; 24(30): 6791-6798.
39. Bourin M, Hascoet M, Colombel MC, et al. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants: possible roles of serotoninergic systems. Eur Neuropsychopharmacol 1996; 6(3):231-236.
40. Redrobe JP, Bourin M. Evidence of the activity of lithium on 5-HT1B receptors in the mouse forced swimming test: comparison with carbamazepine and sodium valproate. Psychopharmacology (Berl) 1999; 141(4):370-377.
41. Bersudsky Y, Shaldubina A, Belmaker RH. Lithium’s effect in forced-swim test is blood level dependent but not dependent on weight loss. Behav pharmacol 2007; 18(1):77-80.
42. Einat H, Yuan P, Gould TD, et al. The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J Neurosci 2003; 23(19):7311-7316.
43. Einat H, Manji HK, Gould TD, et al. Possible involvement of the ERK signaling cascade in bipolar disorder: behavioral leads from the study of mutant mice. Drug News Perspect 2003; 16(7):453-463.
44. Einat H, Manji HK. Cellular plasticity cascades: gene to behavior pathways in animal models of bipolar disorder. Biological Psychiatry 2006; 59(12):1160-1171.
45. Gessa GL, Pani L, Fadda P, et al. Sleep deprivation in the rat: an animal model of mania. Eur Neuropsychopharmacol 1995; 5(suppl):89-93.
46. Antelman SM, Caggiula AR, Kucinski BJ, et al. The effects of lithium on a potential cycling model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22(3):495-510.
47. Einat H, Kofman O, Belmaker RH. Animal models of bipolar disorder: from a single episode to progressive cycling models. In: Myslobodsky M, Weiner I, eds. Contemporary Issues in Modeling Psychopharmacology. Boston: Kluwer Academic Publishers, 2000:165-180.
48. Bersudsky Y, Patishi Y, Bitsch Jensen J, et al. The effect of acute and chronic lithium on forskolin-induced reduction of rat activity. J Neural Transm 1997; 104(8-9):943-952.
49. Kofman O, Sherman WR, Katz V, et al. Restoration of brain myo-inositol levels in rats increases latency to lithium-pilocarpine seizures. Psychopharmacology (Berl) 1993; 110(1-2):229-234.
50. Einat H, Kofman O, Itkin O, et al. Augmentation of lithium’s behavioral effect by inositol uptake inhibitors. J Neural Transm 1998; 105(1):31-38.
51. Berridge MJ, Irvine RF. Inositol phosphates and cell signalling. Nature 1989; 341(6239): 197-205.
52. Nestler EJ, Gould E, Manji H, et al. Preclinical models: status of basic research in depression. Biol Psychiatry 2002; 52(6):503-528.
53. Willner P. The validity of animal models of depression. Psychopharmacology (Berl) 1984; 83(1):1-16.
54. Einat H. Modelling facets of mania - new directions related to the notion of endophenotypes. J Psychopharmacol 2006; 9:9.
55. Einat. Establishment of a battery of simple models for facets of bipolar disorder: a practical approach to achieve increased validity, better screening and possible insights into endophenotypes of disease. Behavior Genetics 2007; 37(1):244-255.
56. Malatynska E and Knapp RJ. Dominant-submissive behavior as models of mania and depression. Neurosci Biobehav Rev 2005; 29(4-5):715-737.
57. Kalynchuk LE, Pinel JP, Treit D, et al. Changes in emotional behavior produced by long-term amygdala kindling in rats. Biol Psychiatry 1997; 41(4):438-451.
58. Kalynchuk LE, Pinel JP, Treit D, et al. Persistence of the interictal emotionality produced by long-term amygdala kindling in rats. Neuroscience 1998; 85(4): 1311-1319.
59. Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28(2):209-224.
60. Shih RA, Belmonte PL, Zandi PP. A review of the evidence from family, twin and adoption studies for a genetic contribution to adult psychiatric disorders. Int Rev Psychiatry 2004; 16(4):260-283.
61. Kieseppa T, Partonen T, Haukka J, et al. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry 2004; 161(10):1814-1821.
62. Craddock N, Jones I. Molecular genetics of bipolar disorder. Br J Psychiatry 2001; 178(suppl 41):S128-S133.
63. Isgor C, Slomianka L, Watson SJ. Hippocampal mossy fibre terminal field size is differentially affected in a rat model of risk-taking behaviour. Behav Brain Res 2004; 153(1):7-14.
64. Kabbaj M, Devine DP, Savage VR, et al. Neurobiological correlates of individual differences in novelty-seeking behavior in the rat: differential expression of stress-related molecules. J Neurosci 2000; 20(18):6983-6988.
65. Taghzouti K, Lamarque S, Kharouby M, et al. Interindividual differences in active and passive behaviors in the forced-swimming test: implications for animal models of psychopathology. Biol Psychiatry 1999; 45(6):750-758.
66. Cohen H, Zohar J. An animal model of posttraumatic stress disorder: the use of cut-off behavioral criteria. Ann NY Acad Sci 2004; 1032:167-178.
67. Cohen H, Zohar J, Matar M. The relevance of differential response to trauma in an animal model of posttraumatic stress disorder. Biol Psychiatry 2003; 53(6):463-473.
68. Cohen H, Zohar J, Matar MA, et al. Setting apart the affected: the use of behavioral criteria in animal models of post traumatic stress disorder. Neuropsychopharmacology 2004; 29(11):1962-1970.
69. Cohen H, Zohar J, Matar MA, et al. Unsupervised fuzzy clustering analysis supports behavioral cutoff criteria in an animal model of posttraumatic stress disorder. Biol Psychiatry 2005; 58(8):640-650. Epub 2005 Jun 22.
70. Nielsen CK, Arnt J, Sanchez C. Intracranial self-stimulation and sucrose intake differ as hedonic measures following chronic mild stress: interstrain and interindividual differences. Behav Brain Res 2000; 107(1-2):21-33.
71. Dietz DM, Tapocik J, Gaval-Cruz M, et al. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine. Physiol Behav 2005; 86(3):347-355. Epub 2005 Aug 29.
72. Overstreet DH, Rezvani AH, Janowsky DS. Genetic animal models of depression and ethanol preference provide support for cholinergic and serotonergic involvement in depression and alcoholism. Biol Psychiatry 1992; 31(9):919-936.
73. Kamens HM, Burkhart-Kasch S, McKinnon CS, et al. Sensitivity to psychostimulants in mice bred for high and low stimulation to methamphetamine. Genes Brain Behav 2005; 4(2):110-125.
74. Willner P, ed. Behavioral models in psychopharmacology: theoretical, industrial and clinical perspectives. In: Behavioral Models in Psychopharmacology. Cambridge: Cambridge University Press, 1991:3-19.
75. Ebner K, Wotjak CT, Landgraf R, et al. Neuroendocrine and behavioral response to social confrontation: residents versus intruders, active versus passive coping styles. Horm Behav 2005; 47(1):14-21.
76. Tecott LH, Nestler EJ. Neurobehavioral assessment in the information age. Nat Neurosci 2004; 7(5):462-466.